Advent Capital Management’s Amgen AMGN Stock Holding History

Advent Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,500	Closed	-$2.09M	–	224
2025 Q2	$2.09M	Buy	+7,500	New	+$2.12M	0.04%	177

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Advent Capital Management's AMGN Position: Q4 2025 in Review

Advent Capital Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 16,000 shares — an estimated $4.52M sold.

Advent Capital Management first reported a position in AMGN in Q3 2015 and held it in 14 quarters. The position peaked at $6.46M in Q2 2017. 3,085 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

Advent Capital Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
Advent Capital Management sold 16,000 Amgen shares in Q4 2025, an estimated $4.52M.
Advent Capital Management first reported a position in Amgen in Q3 2015 and held it in 14 quarters.
Advent Capital Management's Amgen position peaked at $6.46M in Q2 2017.
3,085 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Advent Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.